Key protein a possible new target in the treatment of pancreatic cancer
Advanced pancreatic cancer is often symptomless, leading to late diagnosis only after metastases have spread…
Browsing: Pancreatic Cancer
Researchers succeed at removing some types of pancreatic cancer in animal models
Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer…
AACR 2019: PARP inhibitors can shrink tumours in pancreatic cancer patients with specific mutations
Switching pancreatic cancer patients to the PARP inhibitor rucaparib as maintenance therapy instead of continuing…
AACR 2019: Excess body weight before 50 is associated with higher risk of dying from pancreatic cancer
Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk…
AACR 2019: CD40 combination therapy can shrink pancreatic tumours
A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumours to shrink in…
AACR 2019: Maintenance therapy with rucaparib shows clinical responses in a subgroup of patients with pancreatic cancer
Maintenance treatment with the PARP inhibitor rucaparib was well tolerated and provided clinical responses among…
Tumour-associated immune cells hinder frontline chemotherapy drug in pancreatic cancer
A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because…
Researchers identify potential new combination treatment for pancreatic cancer
Researchers have identified a possible new therapeutic strategy using two types of drug inhibitors at…
Oral bacteria in pancreas linked to more aggressive tumours
The presence of oral bacteria in so-called cystic pancreatic tumours is associated with the severity…
Global study of pancreatic cancer offers possible insights into treatment and early detection
Aatur Singhi, University of Pittsburgh When “Jeopardy!” episode 7059 aired on April 30, 2015, the…